Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Protest actions planned for 12-14 March 2008
2008-03-13

Three protest actions will take place on the Main Campus of the University of the Free State (UFS) in Bloemfontein this week.

Although the interim court interdict granted to the UFS on 6 March 2008 is still in force, permission for the three protests was granted by the Mangaung Local Municipality and the court, in the presence of the university lawyer. Strict conditions have been set for these protest actions.

The UFS management respects the right to peaceful protest and also shares the sentiment of the protesters regarding the reprehensible Reitz video. However, strict conditions have been set for these protest actions as students are writing tests and the normal academic activities should not be disrupted.

Already the first picket protest took place today, Wednesday, 12 March 2008, by about 300 Satawu and Nehawu members. This was not a march and no memorandum was handed over.

On Thursday, 13 March 2008, Nehawu will again picket in front of the Main Building from 13:00 to 14:00. This event must be peaceful. This too is not a march and no memorandum will be handed over.

On Friday, 14 March 2008, a march of Cosatu and Nehawu will take place, starting in the city centre. The march will enter through the Nelson Mandela Drive gate and will enter the campus grounds.

However, it will be limited to the incoming lane of Chancellors Avenue from the Main Gate to the crossing with Alumni Avenue (in front of the Odeion building). Speeches will be made and a memorandum will be handed over.

It is expected that the march will reach the campus at approximately 10:00 and from then the Nelson Mandela Gate to the UFS will be closed for all traffic. The march must end by 14:00. The marchers will return to the city centre and may cause a traffic problem in Nelson Mandela Drive.

The South African Police Service (SAPS) and the UFS’s Protection Services Division will monitor all these actions. Staff, students and visitors to the campus are kindly requested to use alternative gates to the Nelson Mandela entrance on Friday. Academic activities will continue as normal this week.

Media Release
Issued by: Anton Fisher
Director: Strategic Communication
Tel: 051 401 3422
Cell: 072 207 8334
E-mail: fishera.stg@ufs.ac.za  
12 March 2008


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept